Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Unfortunately, that isnt always the case, and patient safety is where we draw a hard line
Where do lipotropics fit relative to GLP-1/GIP medicines
Misleading promotions may trigger enforcement actions, reputational harm, and litigation
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks Patients on semaglutide lost an average of 13.7% of their body weight over the same period 47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide Tirzepatide also produced greater reductions in waist circumference across all dose comparisons A 2024 meta-analysis published in JAMA Internal Medicine analyzing real-world data from over 140,000 patients confirmed the same pattern: tirzepatide produced an average of 4.23 kg more weight loss than semaglutide across all doses and durations studied
US$ 26.75
US$ 29.57
US$ 28.59
